BioNTech-Pfizer say COVID-19 vaccine 100 pct effective on 12 to 15-year-olds
Featured:
|
ADVERTISEMENT
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
BioNTech-Pfizer say COVID-19 vaccine 100 pct effective on 12 to 15-year-olds
Agence France-Presse
Published Mar 31, 2021 07:02 PM PHT
|
Updated Mar 31, 2021 07:13 PM PHT
BioNTech-Pfizer said Wednesday their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year.
BioNTech-Pfizer said Wednesday their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year.
Phase 3 trials carried out on 2,260 adolescents in the United States "demonstrated 100 percent efficacy and robust antibody responses," the companies said in a statement.
Phase 3 trials carried out on 2,260 adolescents in the United States "demonstrated 100 percent efficacy and robust antibody responses," the companies said in a statement.
More details to follow.
More details to follow.
RELATED VIDEO:
RELATED VIDEO:
ADVERTISEMENT
ADVERTISEMENT
